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Abstract
Objective:  Evaluate  the  Neonatal  Screening  Program  of  the  Health  Secretariat  of  the  State  of
Santa Catarina  for  sickle-cell  disease,  from  January  2003  to  December  2012,  regarding  program
coverage and  disease  frequency.
Methods:  Descriptive,  observational,  cross-sectional  study  with  retrospective  data  collection.
The variables  analyzed  were:  number  of  live  births  in  the  State  of  Santa  Catarina;  number  of
screened  children;  number  of  children  diagnosed  with  sickle-cell  trait  and  sickle-cell  disease;
type of  sickle-cell  disease  diagnosed;  age  at  the  time  of  sample  collection,  ethnicity/skin  color,
gender, and  origin  of  children  with  sickle-cell  disease.  Descriptive  measures  and  frequency
tables were  used  for  data  analysis.
Results:  During  the  study  period,  there  were  848,833  live  births  and  730,412  samples  were
screened by  the  program,  resulting  in  a  coverage  of  86.0%.  There  were  6173  samples  positive
for sickle-cell  trait  and  39  for  sickle-cell  disease.  Among  children  with  sickle-cell  disease,  the
median age  at  the  time  of  sample  collection  was  6  days.  Regarding  the  ethnicity/skin  color,
25 (64.1%)  children  were  white,  seven  were  black,  and  seven  others  were  not  speciﬁed.  The
Midwest and  the  Highland  (Planalto  Serrano)  of  Santa  Catarina  were  the  regions  with  the  highest
incidence of  sickle-cell  disease.
Conclusion:  Coverage  by  the  Neonatal  Screening  Program  of  Santa  Catarina  is  good,  but  did  not
demonstrate  an  improvement  trend  over  the  years.  The  frequency  of  sickle-cell  disease  is  low
and lower  than  in  the  North,  Northeast,  and  Midwest  regions.  The  median  age  in  days  at  the
time of  collection  is  older  than  the  age  recommended  by  the  Ministry  of  Health.
© 2016  Sociedade  Brasileira  de  Pediatria.  Published  by  Elsevier  Editora  Ltda.  This  is  an  open
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Avaliac¸ão  de  um  programa  de  triagem  neonatal  para  doenc¸a falciforme
Resumo
Objetivo:  avaliar  o  Programa  de  Triagem  Neonatal  da  Secretaria  de  Saúde  do  Estado  de  Santa
Catarina (PTN-SES/SC)  para  doenc¸a  falciforme  no  período  de  janeiro  de  2003  a  dezembro  de
2012, em  relac¸ão  à  sua  cobertura  e  à  frequência  da  doenc¸a.
Métodos:  estudo  descritivo,  observacional  e  transversal  com  coleta  retrospectiva  dos  dados.
As variáveis  analisadas  foram:  número  de  nascidos-vivos  no  Estado  de  Santa  Catarina;  número
de crianc¸as  triadas;  número  de  crianc¸as  diagnosticadas  com  trac¸o e  doenc¸a  falciforme  (DF);
tipo de  DF  diagnosticada;  idade  da  coleta,  cor/rac¸a,  sexo  e  procedência  das  crianc¸as  com  DF.
Foram utilizadas  as  medidas  descritivas  e  as  tabelas  de  frequência  para  análise  dos  dados.
Resultados:  no  período  estudado,  houve  848.833  nascidos-vivos  e  730.412  amostras  triadas  pelo
programa,  gerando  cobertura  de  86,0%.  Das  amostras  triadas,  foram  encontradas  6.173  crianc¸as
com trac¸o falciforme  e  39  com  DF.  Entre  as  crianc¸as  com  DF,  a  mediana  da  idade  em  dias  na
data da  coleta  foi  de  6.  Das  39  crianc¸as  doentes,  25  (64,1%)  eram  da  cor/rac¸a  branca,  7  da
negra e  7  de  outra  cor/rac¸a.  As  regiões  do  planalto  serrano  e  do  meio-oeste  de  Santa  Catarina
foram as  regiões  com  maior  incidência  de  DF.
Conclusões:  a  cobertura  do  PTN-SES/SC  é  boa,  contudo  não  apresentou  tendência  de  melhora
ao longo  dos  anos.  A  frequência  da  DF  é  baixa  e  menor  que  nas  regiões  Norte,  Nordeste  e
Centro-oeste.  A  mediana  da  idade  em  dias  no  momento  da  coleta  está  acima  do  preconizado
pelo Ministério  da  Saúde.
© 2016  Sociedade  Brasileira  de  Pediatria.  Publicado  por  Elsevier  Editora  Ltda.  Este e´ um  artigo
Open Access  sob  uma  licenc¸a  CC  BY-NC-ND  (http://creativecommons.org/licenses/by-nc-nd/4.
0/).
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ickle-cell  disease  (SCD)  represents  a  group  of  autosomal-
ecessive  inherited  hematological  diseases,  which  includes
everal  genotypes,  with  a  prevalence  of  hemoglobin  S
HbS).1--3 The  presence  of  this  abnormal  hemoglobin  is
esponsible  for  the  main  clinical  manifestations  of  the  dis-
ase,  which  originate  from  vaso-occlusive  phenomena  and
hronic  ischemic  disorders.4
The  distribution  of  SCD  is  a  heterogeneous  one  and  is
ore  common  among  those  of  African  ascendancy.  According
o  2009  data  from  the  Brazilian  Institute  of  Geography  and
tatistics  (Instituto  Brasileiro  de  Geograﬁa  e  Estatística  --
BGE),  in  Brazil,  black  and  brown  individuals  represented
.9%  and  44.2%  of  the  population,  respectively,  reﬂecting
he  heterogeneity  of  SCD  in  the  country.5
In  June  2001,  through  Ministry  of  Health  Decree  No.  822,
everal  diseases  were  added  to  the  list  of  those  screened
hrough  the  existing  National  Neonatal  Screening  Program
NSP)  (phenylketonuria  and  congenital  hypothyroidism),  to
nclude  the  detection  of  SCD  and  other  hemoglobinopathies,
s  well  as  cystic  ﬁbrosis.6 The  diagnosis  of  SCD  is  per-
ormed  by  a  laboratory  through  the  detection  of  HbS
nd  its  association  with  quantitative  fractions  of  other
emoglobins.
The  NSP,  together  with  multidisciplinary  care,  has
llowed  a  signiﬁcantly  reduction  in  morbidity  and  mortality
rom  the  disease,  as  shown  by  studies  in  other  countries.6
The  aim  of  this  study  was  to  evaluate  the  NSP  of  the
ealth  Secretariat  of  the  State  of  Santa  Catarina  (Pro-
rama  de  Triagem  Neonatal  da  Secretaria  da  Saúde  do
stado  de  Santa  Catarina  [NSP-SES/SC])  for  SCD  and  other
emoglobinopathies  in  relation  to  their  coverage  and  the
t
s
sncidence  of  SCD  and  sickle-cell  trait  from  January  2003  to
ecember  2012.
ethods
his  was  a  descriptive,  observational,  cross-sectional  study
pproved  by  the  Ethics  Committee  of  Hospital  Infantil  Joana
e  Gusmão  under  opinion  No.  029/2013.
The  assessed  variables  were  obtained  retrospectively
rom  a  database  at  the  Central  Laboratory  (Laboratório  Cen-
ral  [LACEN])  of  the  Health  Secretariat  of  the  State  of  Santa
atarina  (Secretaria  da  Saúde  do  Estado  de  Santa  Catarina
SES/SC])  and  the  Live  Birth  Information  System  (Sistema  de
nformac¸ões  sobre  Nascidos  Vivos  [SINASC]).  The  collected
ata  comprise  the  period  from  January  2003  to  December
012.
The  variables  included:  number  of  live  births  in  the  State
f  Santa  Catarina;  number  of  children  screened  by  the  NSP-
ES/SC  for  SCD  and  other  hemoglobinopathies;  number  of
hildren  diagnosed  with  SCD  and  sickle-cell  trait  by  the
SP-SES/SC;  type  of  SCD  diagnosed  by  the  aforementioned
rogram;  ﬁnal  diagnosis  of  children  whose  ﬁrst  samples  were
nconclusive;  age  at  collection,  ethnicity/skin  color,  gender,
nd  origin  of  children  with  SCD  according  to  the  macro-
egions  of  Santa  Catarina.7
Regarding  the  variable  ethnicity/skin  color,  it  used  the
riterion  established  by  the  Brazilian  Institute  of  Geography
nd  Statistics  (Instituto  Brasileiro  de  Geograﬁa  e  Estatística
IBGE]).5 The  information  on  this  variable  was  obtained  from
he  ﬁle  completed  by  the  nursing  staff  at  the  time  of  blood
ample  collection.
Blood  sample  collection  was  carried  out  by  the  nursing
taff  in  hospitals,  maternity  hospitals,  or  basic  health  units
isease  411
Table  2  Number  of  children  with  sickle-cell  trait  and  dis-
ease  diagnosed  by  the  Neonatal  Screening  Program  of  the
Health  Secretariat  of  the  State  of  Santa  Catarina,  from  Jan-
uary 2003  to  December  2012.
Year  FAS  pattern  FS  pattern  FSC  pattern  FSA  pattern
2003  491  3  2  0
2004 666  5  1  0
2005 655  3  2  1
2006 550  3  2  0
2007 607  0  0  0
2008 692  2  3  0
2009 659  6  1  0
2010 509  1  0  0
2011 683  1  0  0
2012 661  2  1  0
Total 6173  26  12  1
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in  the  municipalities  of  Santa  Catarina.  The  sample,  taken
from  the  child’s  heel  and  deposited  on  ﬁlter  paper  discs,  was
later  sent  to  LACEN  for  analysis.
The  method  used  to  test  blood  samples  was  high-
performance  liquid  chromatography  associated  with  the
cation-exchange  chromatography,  using  the  Variant  II  device
(Bio-Rad®,  CA,  USA).
Samples  with  results  different  from  the  Hb  FA  pat-
tern  were  submitted  to  another  distinct  chromatography
test.  The  isoelectric  focusing  test  was  usually  used  for  this
assessment.  When  the  results  of  both  tests  were  distinct,
constituting  an  inconclusive  result,  the  child  was  called  for
a  new  sample  collection.
Children  whose  samples  had  an  indeterminate  result,
i.e.,  a  hemoglobin  type  different  from  the  hemoglobin  that
can  be  identiﬁed  by  standard  screening  tests,  were  referred
for  diagnostic  clariﬁcation  at  Hospital  Infantil  Joana  de  Gus-
mão  (HIJG),  a  referral  center  in  the  State  of  Santa  Catarina
for  neonatal  screening  tests.
Descriptive  measures  and  frequency  tables  were  used  for
analysis  of  the  results.
Results
From  January  2003  to  December  2012,  730,412  samples  were
submitted  to  screening  test  of  the  NSP-SES/SC.  During  this
period,  848,833  children  were  born  in  the  state,  accord-
ing  to  SINASC,  which  indicates  a  program  coverage  of  86.0%
(Table  1).
SCD  was  identiﬁed  in  39  children  of  the  screened  sam-
ples.  Of  these,  26  cases  showed  the  FS  pattern  (in  order  of
decreasing  quantity,  presence  of  hemoglobins  F  and  S,  in  the
absence  of  hemoglobin  A);  12  FSC  (presence  of  hemoglobins
F,  S  and  C,  in  the  absence  of  hemoglobin  A);  and  one  FSA
(presence  of  hemoglobins  F,  S  and  A;  Table  2).  Each  of  these
samples  was  submitted  to  two  tests  --  high-performance
liquid  chromatography  and  isoelectric  focusing  --  with
Table  1  Number  of  live  births,  screened  children,  and  per-
centage  of  coverage  of  the  Neonatal  Screening  Program  of
the Health  Secretariat  of  the  State  of  Santa  Catarina,  from
January  2003  to  December  2012.
Year Live  birthsa Screened  childrenb Coverage
2003  83,177  67,993  81.7%
2004 85,475  80,243  93.9%
2005 84,584  80,333  95.8%
2006 84,133  68,063  80.9%
2007 81,903  69,925  85.4%
2008 85,262  80,172  94.0%
2009 83,489  73,437  88.0%
2010 84,611  61,997  73.3%
2011 87,481  78,127  89.3%
2012 88,772  70,122  78.0%
Total 848,833  730,412  86.0%
No justiﬁcations were found for the low coverage in 2010.
a Live Birth Information System (Sistema de Informac¸ões sobre
Nascidos Vivos [SINASC]).7
b Central Laboratory (Laboratório Central [LACEN]) of the
Health Secretariat of the State of Santa Catarina.
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aSource:  Central Laboratory (Laboratório Central [LACEN]) of the
Health Secretariat of the State of Santa Catarina.
quivalent  results.  Whether  there  was  further  conﬁrmation
f  the  results  with  other  diagnostic  tests  was  not  assessed.
The  result  was  indeterminate  in  302  samples,  i.e.,  the
emoglobin  was  different  from  hemoglobins  that  can  be
iagnosed  by  neonatal  screening  methods.  These  children
ere  referred  to  the  HIJG  for  diagnostic  clariﬁcation.
Of  the  samples  analyzed  by  the  NSP-SES/SC,  41  showed
nconclusive  results  and  25  children  with  these  results  did
ot  undergo  a  second  test,  despite  the  program’s  recommen-
ation.  Of  the  remaining  16  children  that  had  a  new  sample
ollected,  six  once  again  showed  an  inconclusive  pattern,
even  showed  a  normal  pattern,  and  three  had  sickle-cell
rait  pattern.  Thus,  31  children  with  an  inconclusive  pattern
id  not  have  a  deﬁnite  diagnosis  (Fig.  1).
Regarding  the  origin,  the  Midwest  and  Highland  macro-
egions  had  the  highest  percentages  of  SCD  cases  (Table  3).
Regarding  the  skin  color/ethnicity  of  children  with  SCD
patterns  FS,  FSC,  and  FSA),  25  (64.1%)  were  white;  seven
ere  black,  and  seven  were  of  ethnicity/skin  color  not  spec-
ﬁed  in  the  sample  collection  form.  As  for  gender,  24  were
ales  and  15  were  females.  The  mean  age  on  the  sample
ollection  day  was  9.08  days  and  the  median  was  6  days.
iscussion
he  main  result  of  this  study  was  to  conﬁrm  the  frequency
f  SCD  (1:18,728)  and  sickle-cell  trait  (1:118)  in  the  State
f  Santa  Catarina,  as  well  as  the  coverage  of  the  neonatal
creening  program  in  the  state  (86.0%).
The  incidence  of  SCD  was  low,  possibly  due  to  the  small
roportion  of  African  descendants  in  the  State  of  Santa  Cata-
ina.  Blacks,  according  to  IBGE,  accounted  for  only  2.2%,
nd  mixed-race,  11.7%  of  the  state  population  in  the  year
009.5 The  highest  SCD  incidence  occurred  in  the  Midwest
nd  Highland  macro-regions  of  Santa  Catarina.
In  Brazil,  in  2003,  the  incidence  of  SCD  was  1:650  in
ahia,  the  state  with  the  highest  proportion  of  blacks  in  the
opulation,8 while  in  Rio  de  Janeiro  it  was  1:1288  in  2007.9
owever,  a  study  carried  in  2004  in  Rio  Grande  do  Sul  showed
n  incidence  of  SCD  of  1:39,100,10 and  another  performed
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aigure  1  Number  of  live  births,  screened  samples,  and  respe
012.
n  Paraná  between  2002  and  2004  showed  an  incidence  of
:20,320.11
The  observed  coverage  may  not  reﬂect  the  actual
creening  coverage  of  all  live  births.  Even  though  all  the
unicipalities  in  the  state  have  joined  this  program,  some
hildren  may  have  been  screened  in  the  private  health  care
etwork,  which  does  not  generate  record  for  the  NSP-SES/SC
nd  reﬂects  a  failure  of  the  state’s  monitoring  program.
In  studies  conducted  in  Brazil,  it  was  observed  that
he  program  coverage  in  the  Federal  District  was  83.4%
n  200612;  in  Bahia,  88.9%  between  the  years  2007  and
00913;  and  in  Mato  Grosso  do  Sul,  91.8%  between  2006
nd  2010.14 The  goal  of  100%  coverage  of  the  neonatal
creening  programs  is  still  a  challenge,  even  in  more  devel-
ped  countries.9 Canada  and  Belgium,  in  2006,  achieved
overage  of  76%15 and  87%,16 respectively.
Among  the  children  with  SCD  in  the  period  analyzed
n  this  study,  the  mean  age  on  sample  collection  day  was
.58  days  and  the  median  was  6  days,  showing  the  need  to
mprove  these  variables,  as  the  Ministry  of  Health  recom-
ends  that  the  collection  be  performed  between  3  and  5
ays  of  life.  Although  the  test  can  be  performed  later,  it  is
r
s
Table  3  Distribution  of  sickle-cell  disease  per  health  macro-re
December 2012.
Health  macro-region  Number  of  cases  of
sickle  cell  diseasea
Great-West  0  
Midwest 8  
North highlands  1  
Northeast 8  
Itajaí Valley  1  
Itajaí river  estuary  5  
Highland 4  
Greater Florianópolis  10  
South 2  
Total 39  
Source:  Live Birth Information System (Sistema de Informac¸ões sobre
Central [LACEN]) of the Health Secretariat of the State of Santa Catari
a Sickle-cell disease (FS, FSC, and FSA). diagnoses  at  the  NSP-SES/SC,  from  January  2003  to  December
f  utmost  importance  to  collect  the  sample  within  the  ideal
eriod  for  some  of  the  screened  diseases,  in  order  to  provide
arly  diagnosis  and  treatment,  as  well  as  to  beneﬁt  from  the
revention  of  sequelae.
A  higher  number  of  white  patients  was  observed  (64.1%)
mong  the  39  SCD  cases.  The  higher  incidence  of  the  dis-
ase  in  whites  can  be  explained  by  the  higher  number  of
hese  individuals  among  the  State  of  Santa  Catarina’s  pop-
lation,  which,  according  to  2009  IBGE  data,  accounted  for
5.7%  of  the  total  population,5 in  addition  to  the  white  eth-
icity  being  misattributed  to  the  mixed-race  population.
he  data  limitation  regarding  skin  color/ethnicity  originates
rom  the  fact  that  this  information  is  ﬁlled  out  by  the  per-
on  who  completed  the  blood  sample  form  and  not  based
n  a  detailed  family  background  questionnaire,  considering
he  interpretative  disagreement  between  skin  color  and  eth-
icity  of  a  particular  individual.  It  is  essential,  however,  to
e  aware  that  none  of  these  limitations  affect  the  major
spects  assessed  in  this  study.Regarding  children  with  inconclusive  and  indeterminate
esults,  it  is  important  to  create  mechanisms  to  intensify  the
earch  for  these  individuals,  aiming  to  expand  the  program’s
gion  of  the  State  of  Santa  Catarina,  from  January  2003  to
Number  of  live  births
per  region
Incidence
per  region
97,705  0
86,921  1:10,865
56,624  1:56,624
122,663  1:15,333
120,420  1:120,420
76,502  1:15,300
42,259  1:10,565
129,362  1:12,932
116,427  1:58,213
848,883  1:18,728
 Nascidos Vivos [SINASC])7 and Central Laboratory (Laboratório
na.
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scope  and  to  identify  and  provide  early  treatment  to  any
SCD  carriers  --  which  in  this  study  was  of  a  low  frequency,
considering  the  number  of  screened  samples.
One  limitation  of  this  study  is  due  to  lack  of  patient  mon-
itoring  after  diagnosis  through  the  neonatal  screening,  in
order  to  assess  patient  adherence  to  the  interdisciplinary
outpatient  follow-up  and  health  measures  proposed  by  the
program.  Recently,  a  study  performed  in  Minas  Gerais  found
that  neonatal  screening  in  that  state,  even  if  carried  out  in
a  comprehensive  and  effective  manner,  was  not  enough  to
reduce  SCD  mortality,  which  was  7.4%  in  the  ﬁrst  14  years,
with  slightly  more  than  half  of  the  deaths  occurring  before
2  years  of  age.17
The  drastic  reduction  in  mortality  related  to  SCD  in  the
early  years  of  life,  from  26%  to  1--2%,  occurred  due  to  com-
prehensive  care  provided  to  this  population  at  pediatric
referral  centers.  Therefore,  early  diagnosis  and  treatment
of  SCD  helps  to  increase  survival  and  signiﬁcantly  improves
the  quality  of  life  of  these  individuals.6,18
Thus,  it  can  be  concluded  that  the  NSP  has  good  coverage
in  Santa  Catarina  and  that  the  incidence  of  SCD  in  the  state
is  quite  low.  Nevertheless,  it  is  essential  to  assess  patients’
adherence  to  health  measures  recommended  by  the  NSP,  as
without  this  follow-up,  the  diagnosis  alone  becomes  point-
less.  With  the  information  provided  by  this  study,  the  authors
intend  to  seek  the  affected  children  and  assess  adherence
to  outpatient  medical  follow-up,  as  well  as  the  health  sup-
port  offered  to  patients,  in  order  to  actually  evaluate  the
program’s  efﬁcacy.
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